Floatz logo

PRAZOSIN

Portal Hypertension

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauSmall moleculePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
81/ 100

Competitive context

21 Active assets in the Portal Hypertension cohort.

Asset / SponsorPhaseRating
CARVEDILOL
West China Hospital
Phase 4BBB
SIMVASTATIN
Kafrelsheikh University
Phase 4BBB
PROPRANOLOL
West China Hospital
Phase 4BBB
Apixaban
Asian Institute Of Medical Sciences
Phase 4BB
WARFARIN
Northern Jiangsu People's Hospital
Phase 4BB

View all 50 →

Same molecule, other indications

PRAZOSIN is also rated in:

Gastrointestinal HemorrhageDormant
BB
Indicative ·
69 / 100
View asset →
Post-Traumatic HeadacheDormant
BB
Indicative ·
69 / 100
View asset →
dementiaDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →